These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 33201717)
1. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles. Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717 [TBL] [Abstract][Full Text] [Related]
2. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Cui T; Zhang S; Sun H Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466 [TBL] [Abstract][Full Text] [Related]
3. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth. Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606 [TBL] [Abstract][Full Text] [Related]
4. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer. Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174 [TBL] [Abstract][Full Text] [Related]
5. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles. Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles. Feng R; Song Z; Zhai G Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245 [TBL] [Abstract][Full Text] [Related]
7. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model. Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. Kheiri Manjili H; Ghasemi P; Malvandi H; Mousavi MS; Attari E; Danafar H Eur J Pharm Biopharm; 2017 Jul; 116():17-30. PubMed ID: 27756682 [TBL] [Abstract][Full Text] [Related]
9. pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer. Yuan JD; ZhuGe DL; Tong MQ; Lin MT; Xu XF; Tang X; Zhao YZ; Xu HL Artif Cells Nanomed Biotechnol; 2018; 46(sup1):302-313. PubMed ID: 29301415 [TBL] [Abstract][Full Text] [Related]
10. Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Wang BL; Shen YM; Zhang QW; Li YL; Luo M; Liu Z; Li Y; Qian ZY; Gao X; Shi HS Int J Nanomedicine; 2013; 8():3521-31. PubMed ID: 24101869 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282 [TBL] [Abstract][Full Text] [Related]
13. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment. Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601 [TBL] [Abstract][Full Text] [Related]
14. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin. Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915 [TBL] [Abstract][Full Text] [Related]
15. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Ji H; Tang J; Li M; Ren J; Zheng N; Wu L Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628 [TBL] [Abstract][Full Text] [Related]
16. Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration. Duan Y; Zhang B; Chu L; Tong HH; Liu W; Zhai G Colloids Surf B Biointerfaces; 2016 May; 141():345-354. PubMed ID: 26874910 [TBL] [Abstract][Full Text] [Related]
17. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
18. Co-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration. Dian C; Qian Z; Ran M; Yan X; Dian L Int J Nanomedicine; 2024; 19():8603-8620. PubMed ID: 39188859 [TBL] [Abstract][Full Text] [Related]
19. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation. Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567 [TBL] [Abstract][Full Text] [Related]
20. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]